Press releases
- LivaNova to Announce Second-Quarter 2024 Results
- LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
- LivaNova to Present at the Goldman Sachs Healthcare Conference
- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
More ▼
Key statistics
On Monday, LivaNova PLC (L2IV34:SAO) closed at 37.24, 0.00% above its 52-week low of 37.24, set on Jul 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 37.24 |
---|---|
High | 37.24 |
Low | 37.24 |
Bid | 37.67 |
Offer | 37.85 |
Previous close | 37.24 |
Average volume | 33.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 22 2024 20:49 BST.
More ▼